Our keywords and medical subject heading (MeSH) words included SGLT-2 inhibitors, cardiovascular outcomes, renal outcomes, heart failure, chronic kidney disease, and diabetes. We have included the regular keywords and MeSH keywords in the search (Table 1). This evidence concerns the gene SLC5A2 and heart failure.